Background: HIV chronic infection (CI) is characterized by perturbations in B cell homeostasis, phenotype and function. There are limited data describing B cell dynamics during HIV acute infection (AI). Characterizing B cell subsets during AI might help define signatures that shape the humoral response in HIV infection.
Methods: Eleven women who became HIV-1 infected during a longitudinal follow-up study in Durban, South Africa were analyzed. Samples were analyzed at baseline (pre-infection) and weeks 1, 2, 4 and 12 post detection of HIV RNA. Multicolor flow cytometry was used to identify B cell subsets based on expression of CD21CD27 on live CD19+ lymphocytes and defined as follows; activated memory (AM) CD27+CD21-, resting memory (RM) CD27+ CD21+, naïve cells (N) CD27-CD21+, tissue-like memory (TLM) CD27-CD21- and plasmablasts (PBs) CD27+CD38+ cells. Evolution of HIV-specific antibodies and changes in CXCL13 levels were determined by ELISAResults: Compared to a baseline sample, we observed rapid and significant expansion of TLM cells post HIV infection (PI); 1week (p = 0.0003), 2 weeks (p = 0.0018), 1 month (p = 0.046) and 3 months (p= 0.043). In contrast, RM cells were significantly lower throughout AI compared to baseline; 1week (p = 0.0007), 2 weeks (p = 0.016), 1 month (p = 0.019) and 3 months (p= 0.018). We observed significant expansion of AM cells at 2 weeks and 1 month (p = 0.008, p= 0.009 respectively) followed by contraction by 3 months (p = 0.260) PI. Peripheral blood PBs peaked by a median of 17 days (range 7-32 days) PI. Changes in B cell subsets were driven by the increase in viral loads. Levels of CXCL13 a chemokine critical for B cell homing to the germinal centers also increased over time in the first 3 months.
Conclusions: Perturbations in B cell subsets and CXCL13 levels occurs immediately following HIV-1 infection and this may therefore determine the subsequent development of anti-HIV antibodies.